US.TMO · Thermo Fisher Scientific

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.2248138711920933,
        "turnoverUsdM": 743.2902454410271,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.TMO",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 537.0072,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.5,
      "stop_loss_percent": 6.4,
      "take_profit_price": 628.3301,
      "target_multiplier": 2.2,
      "technical_strength": 2,
      "take_profit_percent": 9.5
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.472953227605692,
    "stopLossPercent": 6.449627742384187,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 74,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 67,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 545.314,
    "ma50": 507.2566,
    "close": 574.03,
    "prevClose": 574.3,
    "avgVolume20": 2209343,
    "volumeRatio": 0.59,
    "changePercent": -0.05
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.02591460372555865,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 0.5787148935409479,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.7261198911644938,
      "volat_points": 0,
      "day_range_pct": 0.018971150375131265,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 74,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 14,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 70,
        "contribution": 14
      },
      {
        "raw": 9,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 60,
        "contribution": 9
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 6.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 67,
        "contribution": 6.7
      },
      {
        "raw": 20.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 68,
        "contribution": 20.4
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "謹慎買入",
    "result": 67,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 14/20分",
      "市場環境分析總分: 9/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 6.7/10分",
      "技術信號分析總分: 20.4/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 2.9,
      "資金流": 14,
      "市場環境": 9,
      "情緒分析": 8,
      "技術信號": 20.4,
      "風險管理": 6.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 743.2902454410271,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.TMO",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 3,
            "details": {
              "qqq": {
                "ma20": 699.88099675,
                "ma50": 714.8264005399999,
                "name": "QQQ",
                "close": 700.070007,
                "points": 1
              },
              "spy": {
                "ma20": 746.0140036500002,
                "ma50": 745.31840316,
                "name": "SPY",
                "close": 757.66998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.2248138711920933,
          "atrPoints": 2,
          "cciPoints": 4,
          "vixPoints": 0,
          "marketTrendPoints": 3
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 6,
              "sentimentScoreRaw": 1.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141100875,
                "url": "https://finnhub.io/api/news?id=f3f4d21a89aa82427dddec50d1979ffdcf38762ace0db69ee484a8c55eb94ce4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.",
                "category": "company",
                "datetime": 1785762903,
                "headline": "Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects"
              },
              {
                "id": 141081562,
                "url": "https://finnhub.io/api/news?id=eeedc487b5c846c46ee4f5f5e4ed1e1fb548fe5b030992c9ad5ff7877643d0a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) recently announced strong fiscal Q2 2026 results, with revenue growing 10% to $11.99 billion, GAAP diluted EPS rising 9% to $4.68, and adjusted EPS growing 13% to $6.03. The results prompted several analysts to raise their price targets, but after the post-earnings rally, investors must decide whether the recovery story […]",
                "category": "company",
                "datetime": 1785524963,
                "headline": "Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?"
              },
              {
                "id": 141072943,
                "url": "https://finnhub.io/api/news?id=614ba16e9f9842aff9f6e6cb5d3b9f8e0887863805ff56c40de9c0c76900f08b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) is back in focus after reporting second quarter results that exceeded market expectations, supported by broad-based demand and fresh regulatory clearances across its diagnostics portfolio. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher Scientific’s recent earnings beat and steady flow of product clearances have coincided with a 30-day share price return of 15.04% and a 22.92% 90-day share price return. The 1-year total shareholder return of...",
                "category": "company",
                "datetime": 1785453054,
                "headline": "Thermo Fisher Scientific (TMO) Could Be 2% Undervalued After Q2 Earnings Beat"
              },
              {
                "id": 141006478,
                "url": "https://finnhub.io/api/news?id=cc6fb966b51190772bb482e4fc719c000f75c15cd5f469066321418ef8a4f6c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.5% year on year to $11.99 billion. Its non-GAAP profit of $6.03 per share was 5.6% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784902148,
                "headline": "TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves"
              },
              {
                "id": 141003841,
                "url": "https://finnhub.io/api/news?id=c5e600648acd56b7ae07d5a8e7b74ac3d2d5c7727030691650567887eca1d007",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has been selected by ImmuPharma as the key drug product and contract development manufacturer for its Kapiglucagon diabetes treatment program. The partnership covers development and manufacturing support for Kapiglucagon, an experimental therapy aimed at addressing diabetes. This agreement adds a new project to Thermo Fisher Scientific’s pharmaceutical services portfolio, focused on complex drug development work. For investors tracking Thermo Fisher...",
                "category": "company",
                "datetime": 1784884099,
                "headline": "Thermo Fisher (TMO) Lands ImmuPharma Kapiglucagon Diabetes Manufacturing Role"
              },
              {
                "id": 141002314,
                "url": "https://finnhub.io/api/news?id=6882140af85e1902540603899b9719ddf6434ea1b1b2940ef1d07de01505f939",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) saw its share prices increase by 8.71 percent on Thursday to close at $572.32 apiece, as investors took heart from the strong earnings performance and a series of price target upgrades for its stock. In the second quarter of the year, the company grew its net income by 7 percent […]",
                "category": "company",
                "datetime": 1784862359,
                "headline": "Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades"
              },
              {
                "id": 141001696,
                "url": "https://finnhub.io/api/news?id=32ac35b1c0f7f2bcbf9d0807768059b7dcaefcf05bcd6d75532e2163357428a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Organic revenue beat guidance at 5% as pharma and biotech activity strengthened.",
                "category": "company",
                "datetime": 1784852994,
                "headline": "TMO Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140999607,
                "url": "https://finnhub.io/api/news?id=bbe467cad39af631f088a1e428441bb989a3afbea8de26d0fcc242056852bb21",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc (TMO) reports a 10% revenue increase and raises full-year guidance, driven by innovation and strategic acquisitions.",
                "category": "company",
                "datetime": 1784840577,
                "headline": "Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ..."
              }
            ],
            "raw_source": [
              {
                "id": 141103023,
                "url": "https://finnhub.io/api/news?id=4790310e5ed96b76e44adf51fa3aaeb1d78d172fb9afdc61e8964ee3f9c244bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
                "category": "company",
                "datetime": 1785788002,
                "headline": "3 Cash-Producing Stocks We Think Twice About"
              },
              {
                "id": 141100874,
                "url": "https://finnhub.io/api/news?id=6b8be8e80249eee81328fe41d0208e0f2a4ceb16bcae0bb5c93ebaec58590848",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "TMO lifted its 2026 outlook after Q2 topped estimates, driven by stronger demand, acquisitions and margin gains. Can the momentum continue?",
                "category": "company",
                "datetime": 1785771420,
                "headline": "Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results"
              },
              {
                "id": 141100875,
                "url": "https://finnhub.io/api/news?id=f3f4d21a89aa82427dddec50d1979ffdcf38762ace0db69ee484a8c55eb94ce4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.",
                "category": "company",
                "datetime": 1785762903,
                "headline": "Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects"
              },
              {
                "id": 141082643,
                "url": "https://finnhub.io/api/news?id=05c7ae4fb41773fe01cf10657261a5f6e648120da088da6963ed32991c579eab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Microsoft rides AI, Copilot and Azure growth, but can expanding cloud demand and capacity challenges shape its next phase?",
                "category": "company",
                "datetime": 1785529500,
                "headline": "Top Analyst Reports for Microsoft, Palo Alto Networks & American Express"
              },
              {
                "id": 141081562,
                "url": "https://finnhub.io/api/news?id=eeedc487b5c846c46ee4f5f5e4ed1e1fb548fe5b030992c9ad5ff7877643d0a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) recently announced strong fiscal Q2 2026 results, with revenue growing 10% to $11.99 billion, GAAP diluted EPS rising 9% to $4.68, and adjusted EPS growing 13% to $6.03. The results prompted several analysts to raise their price targets, but after the post-earnings rally, investors must decide whether the recovery story […]",
                "category": "company",
                "datetime": 1785524963,
                "headline": "Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?"
              },
              {
                "id": 141079032,
                "url": "https://finnhub.io/api/news?id=37bec1425901ed97eb3b150eccb768342ed1b73f825ab5e848b348b44ed865c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key as competition intensifies.",
                "category": "company",
                "datetime": 1785504000,
                "headline": "How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends"
              },
              {
                "id": 141072943,
                "url": "https://finnhub.io/api/news?id=614ba16e9f9842aff9f6e6cb5d3b9f8e0887863805ff56c40de9c0c76900f08b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) is back in focus after reporting second quarter results that exceeded market expectations, supported by broad-based demand and fresh regulatory clearances across its diagnostics portfolio. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher Scientific’s recent earnings beat and steady flow of product clearances have coincided with a 30-day share price return of 15.04% and a 22.92% 90-day share price return. The 1-year total shareholder return of...",
                "category": "company",
                "datetime": 1785453054,
                "headline": "Thermo Fisher Scientific (TMO) Could Be 2% Undervalued After Q2 Earnings Beat"
              },
              {
                "id": 141069816,
                "url": "https://finnhub.io/api/news?id=26ef73af2e2d9dd54774b6b3923a4378abfc275210430118f5aef2cae852bbf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Organic revenue still fell, yet a segment returning to growth and a raised outlook were enough to reprice the stock in a single session.",
                "category": "company",
                "datetime": 1785436199,
                "headline": "Avantor Stock Surged Because One Segment Stopped Shrinking"
              },
              {
                "id": 141068356,
                "url": "https://finnhub.io/api/news?id=9f63c88348cc7341889d66a5eff31868c7e394b9c509bf10ca5147c18a54ced7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher’s second quarter saw a notable uptick in end-market activity, propelling results above Wall Street’s expectations and leading to a positive market reaction. Management pointed to stronger demand across pharmaceutical, biotech, industrial, and diagnostics markets, with CEO Marc Casper highlighting “broad-based momentum” and “excellent execution” in core segments such as Bioproduction and Clinical Research. Newly launched high-end instruments and AI-powered software were key contribu",
                "category": "company",
                "datetime": 1785431822,
                "headline": "The Top 5 Analyst Questions From Thermo Fisher’s Q2 Earnings Call"
              },
              {
                "id": 141045284,
                "url": "https://finnhub.io/api/news?id=e230c03b4e1344ce98d6715be8d70854b2f51144a5c95c8a41454206af666ffb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Precision Diagnostics And Medicine Market size & share revenue was valued at approximately USD 147.23 Billion in 2025 and is expected to reach USD 159.66 Billion in 2026 and is expected to reach around USD 345.75 Billion by 2035, at a CAGR of 8.91% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are F. Hoff",
                "category": "company",
                "datetime": 1785259800,
                "headline": "[Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 141044347,
                "url": "https://finnhub.io/api/news?id=9d1faf3fbb5f492ca7dcd5acc084c90757596bc020f0ce93a3e1de57bc03bf56",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce the recipients of its 2026 Top Corporate Supporter Award, a distinction given to companies and organizations that generously support the association through advertising, sponsorships, and exhibits. These significant contributions make it possible for ADLM to further its mission of better health for all through laboratory medicine.",
                "category": "company",
                "datetime": 1785254400,
                "headline": "ADLM announces 2026 Top Corporate Supporter Award recipients and thanks them for their essential backing"
              },
              {
                "id": 141042363,
                "url": "https://finnhub.io/api/news?id=3bfd6133afea3cd76b3c7c19bdd07dc3020ce45f695cfce7c40a19d245fba9d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Jefferies just named five U.S. dividend stocks to its exclusive Global Best Ideas list, and with the S&P 500 stretched to historically expensive valuations, the case for these high-conviction picks has never been more urgent.",
                "category": "company",
                "datetime": 1785243038,
                "headline": "Jefferies Global Best Ideas List Has 5 US Dividend Stocks With Huge Total Return Potential"
              },
              {
                "id": 141046020,
                "url": "https://finnhub.io/api/news?id=817820eb7708f1a426f5cc98eaf8f02a6ac10d6555fb01282b20a888b49dfad2",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Piper Sandler  analyst David Westenberg   maintains Thermo Fisher Scientific (NYSE:TMO) with a Neutral and raises the price target from $510 to $600.",
                "category": "company",
                "datetime": 1785159448,
                "headline": "Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600"
              },
              {
                "id": 141034599,
                "url": "https://finnhub.io/api/news?id=b434d5faeac0b5445fa56257eafccb17c6d90118a5f62fadbf1b9ac29eea1ae3",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Morgan Stanley  analyst Tejas Savant   maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $620 to $650.",
                "category": "company",
                "datetime": 1785155664,
                "headline": "Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650"
              },
              {
                "id": 141032954,
                "url": "https://finnhub.io/api/news?id=4ad71d82f5a3da8fa9ddb3f8bf69adef6aa0a1f3ba9b2d09da9d76f1ae5c1349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., July 27, 2026--Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 26-30, 2026, in Anaheim, Calif. Spanning specialty diagnostics, quality management and the full diagnostic continuum, Thermo Fisher’s presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinical need",
                "category": "company",
                "datetime": 1785155400,
                "headline": "Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026"
              },
              {
                "id": 141032829,
                "url": "https://finnhub.io/api/news?id=e9669444eb7d54da770e3c0dfa28ef3a5858b6c67f0d7a5f6f15443a00e4cf3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "MNST, CRS and USIO highlight Zacks strategies that outperformed amid a volatile market.",
                "category": "company",
                "datetime": 1785154500,
                "headline": "Beat the Market Like Zacks: Monster Beverage, Carpenter Tech, Usio in Focus"
              },
              {
                "id": 141014032,
                "url": "https://finnhub.io/api/news?id=c4530315c69f8f4c69de402a2c6095d082f2dfc439c28a4d59602d188d7b1f9c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/91630492/image_91630492.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "With 27% of S&P 500 companies reporting, 86% have beaten earnings estimates and 80% have exceeded revenue expectations, according to FactSet. Read more here.",
                "category": "company",
                "datetime": 1784943300,
                "headline": "This Week's Market Wrap: Earnings, Inflation, And AI-Driven Spending Concerns"
              },
              {
                "id": 141007834,
                "url": "https://finnhub.io/api/news?id=54f380c9dcf553d768a42732a713ec3932fb49f4553e578393a0c744eb923616",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific's (TMO) broad-based improvement in Q2 is not enough to \"meaningfully\" chang",
                "category": "company",
                "datetime": 1784911968,
                "headline": "Thermo Fisher Scientific's Strong Q2 Not Enough to 'Meaningfully' Change H2 Outlook, RBC Says"
              },
              {
                "id": 141010556,
                "url": "https://finnhub.io/api/news?id=756ebdb8b0c710884f696aad5c96d8654f10e655a244433181d5f8bc27e57f8c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/West-Bangal--India---April-20--2022--Dan.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Dan Loeb reduced his Danaher stake and exited Thermo Fisher in Q1 2026 as the billionaire investor trimmed life sciences exposure.",
                "category": "company",
                "datetime": 1784902999,
                "headline": "Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets"
              },
              {
                "id": 141006478,
                "url": "https://finnhub.io/api/news?id=cc6fb966b51190772bb482e4fc719c000f75c15cd5f469066321418ef8a4f6c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.5% year on year to $11.99 billion. Its non-GAAP profit of $6.03 per share was 5.6% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784902148,
                "headline": "TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves"
              },
              {
                "id": 141006393,
                "url": "https://finnhub.io/api/news?id=1dfc4577cd702e1eaeb68a1f0796e616b438d56f83ddf032c1c7946da8e3fed3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Companies in The News Are: TMO, TSLA, UNP, CSX",
                "category": "company",
                "datetime": 1784899380,
                "headline": "Company News for July 24, 2026"
              },
              {
                "id": 141042576,
                "url": "https://finnhub.io/api/news?id=3d661936daf01f8231570778c993ea5f1ff67b4416f829104e4638964fd6b88e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Moby summary of Thermo Fisher Scientific Inc.'s Q2 2026 earnings call",
                "category": "company",
                "datetime": 1784896200,
                "headline": "Thermo Fisher Scientific Inc. Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141005352,
                "url": "https://finnhub.io/api/news?id=4d73431f2c3617f58fa67a24b0853a1ef831c63ec81636bc814893cef053e08a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Danaher's latest earnings call saw analysts repeatedly test one sore spot in an otherwise solid quarter, and management's answers reveal the key risk for investors now.",
                "category": "company",
                "datetime": 1784895812,
                "headline": "Reading Between The Lines Of DHR's Latest Call"
              },
              {
                "id": 141010557,
                "url": "https://finnhub.io/api/news?id=f635577c9f1a0fcabaa58b2f9907d3ae8dee7520acade64db00e3b7479a2c34e",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "RBC Capital  analyst Dan Leonard   maintains Thermo Fisher Scientific (NYSE:TMO) with a Sector Perform and raises the price target from $490 to $580.",
                "category": "company",
                "datetime": 1784892498,
                "headline": "RBC Capital Maintains Sector Perform on Thermo Fisher Scientific, Raises Price Target to $580"
              },
              {
                "id": 141004461,
                "url": "https://finnhub.io/api/news?id=190e75353b466c18389c0c072d4fea785217aad75c95c6184b041c01dd2daad4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo’s Q2 performance was driven by its laboratory products and biopharma services business with profits around $6.69bn equating to a 12% uptick YoY.",
                "category": "company",
                "datetime": 1784892321,
                "headline": "Thermo Fisher raises 2026 outlook after 10% growth in Q2"
              },
              {
                "id": 141010558,
                "url": "https://finnhub.io/api/news?id=2ba3093fa30612c6a0405e3cbabc3691d7791346baa9f1ee6e8e4df4df375a1d",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Barclays  analyst Luke Sergott   maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $625 to $650.",
                "category": "company",
                "datetime": 1784891933,
                "headline": "Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650"
              },
              {
                "id": 141003841,
                "url": "https://finnhub.io/api/news?id=c5e600648acd56b7ae07d5a8e7b74ac3d2d5c7727030691650567887eca1d007",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has been selected by ImmuPharma as the key drug product and contract development manufacturer for its Kapiglucagon diabetes treatment program. The partnership covers development and manufacturing support for Kapiglucagon, an experimental therapy aimed at addressing diabetes. This agreement adds a new project to Thermo Fisher Scientific’s pharmaceutical services portfolio, focused on complex drug development work. For investors tracking Thermo Fisher...",
                "category": "company",
                "datetime": 1784884099,
                "headline": "Thermo Fisher (TMO) Lands ImmuPharma Kapiglucagon Diabetes Manufacturing Role"
              },
              {
                "id": 141002314,
                "url": "https://finnhub.io/api/news?id=6882140af85e1902540603899b9719ddf6434ea1b1b2940ef1d07de01505f939",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) saw its share prices increase by 8.71 percent on Thursday to close at $572.32 apiece, as investors took heart from the strong earnings performance and a series of price target upgrades for its stock. In the second quarter of the year, the company grew its net income by 7 percent […]",
                "category": "company",
                "datetime": 1784862359,
                "headline": "Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades"
              },
              {
                "id": 141002315,
                "url": "https://finnhub.io/api/news?id=f6e2819a15ff080512e8cde110711147124885915b5628ab5d1b402c14209a6a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) reported stronger-than-expected second-quarter 2026 results and raised its full-year outlook, citing improving customer activity across end markets, broad-based growth and contributions from recent acquisitions. Chairman and Chief Executive Officer Marc Casper sa",
                "category": "company",
                "datetime": 1784858726,
                "headline": "Thermo Fisher Scientific Q2 Earnings Call Highlights"
              },
              {
                "id": 141001696,
                "url": "https://finnhub.io/api/news?id=32ac35b1c0f7f2bcbf9d0807768059b7dcaefcf05bcd6d75532e2163357428a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Organic revenue beat guidance at 5% as pharma and biotech activity strengthened.",
                "category": "company",
                "datetime": 1784852994,
                "headline": "TMO Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140999607,
                "url": "https://finnhub.io/api/news?id=bbe467cad39af631f088a1e428441bb989a3afbea8de26d0fcc242056852bb21",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc (TMO) reports a 10% revenue increase and raises full-year guidance, driven by innovation and strategic acquisitions.",
                "category": "company",
                "datetime": 1784840577,
                "headline": "Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ..."
              },
              {
                "id": 140997115,
                "url": "https://finnhub.io/api/news?id=2dc5c73f42c70ceb223c39789ca8fffdc01973a9abe48a2cfb8eb91f246ad1fc",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1784833500,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 140995778,
                "url": "https://finnhub.io/api/news?id=44e41ed78fcf0cbec34961ce765001922373f26b941224a650dc205af432bd18",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Thursday's session.",
                "category": "company",
                "datetime": 1784826300,
                "headline": "Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session."
              },
              {
                "id": 140997709,
                "url": "https://finnhub.io/api/news?id=0d93a5a957f03bdfcfd55a5f00a7b346126bb659bd02df00086be8f830be117f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 9.7% in the afternoon session after the company reported strong second-quarter earnings that beat Wall Street's estimates for both profit and revenue. For the quarter, the company reported adjusted earnings per share of $6.03, topping expectations of $5.71. Revenue came in at $11.99 billion, a 10.5% year-over-year increase that surpassed Wall Street's forecasts of $11.72 billion. Organic revenue also grew by 5% year on year. Further",
                "category": "company",
                "datetime": 1784825551,
                "headline": "Why Is Thermo Fisher (TMO) Stock Rocketing Higher Today"
              },
              {
                "id": 140997305,
                "url": "https://finnhub.io/api/news?id=be5e7cc5328941b581bc95e3b8b0e924ced967222c665ed9c3c308df4d7b6d12",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call July 23, 2026 8:30 AM EDTCompany ParticipantsRafael Tejada - Vice President of Investor...",
                "category": "company",
                "datetime": 1784820675,
                "headline": "Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141010559,
                "url": "https://finnhub.io/api/news?id=6411f8327837f372e54bb47882e21466a2489f39d68d64303eb341d1b9ecd79d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/23/Thermo-Fisher-Scientific--Inc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher beat second-quarter earnings and revenue estimates, raised 2026 guidance, and cited stronger customer activity across key end markets.",
                "category": "company",
                "datetime": 1784819233,
                "headline": "Thermo Fisher Points to Improving End-Market Activity"
              },
              {
                "id": 140993990,
                "url": "https://finnhub.io/api/news?id=5206b71e1b095efb2af34273688ebb056f5dbbce6ba73d7fae75c33032ce9e3b",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "Let's have a look at the S&P500 gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1784817301,
                "headline": "Which S&P500 stocks are gapping on Thursday?"
              },
              {
                "id": 140994690,
                "url": "https://finnhub.io/api/news?id=e8aaac5769731a4235ef98fb915fed6413b00f1b086d0d3b9c55985f925f7c3f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Biopharmaceutical production led applications in 2025, while sera, media and reagents dominated consumables. Asia-Pacific is expected to record the fastest growth through 2031. Key players include Thermo Fisher Scientific, Danaher, Sartorius, Merck and Corning. Cell Culture Market Cell Culture Market Dublin, July 23, 2026 (GLOBE NEWSWIRE) -- The \"Cell Culture Market by Consumables, Vessels, Equipment, Application, Competition - Global Forecast to 2031\" has been added to ResearchAndMarkets.com's",
                "category": "company",
                "datetime": 1784816280,
                "headline": "Cell Culture Market Analysis by Consumables, Vessels, Equipment, Application, and Competition - Global Forecast to 2031"
              },
              {
                "id": 140994691,
                "url": "https://finnhub.io/api/news?id=7e710b46240704d0856571ac4bd9402c25d758a8f076a5178cab331d2433d515",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Featuring Thermo Fisher Scientific, Agilent Technologies, Merck, Eurofins Scientific, Charles River Labs and Other Key Players In Vitro Toxicology Testing Market In Vitro Toxicology Testing Market Dublin, July 23, 2026 (GLOBE NEWSWIRE) -- The \"In Vitro Toxicology Testing Market by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region, Competition - Global Forecast to 2031\" has been added to ResearchAndMarkets.com's offering. The global in vitro toxicology testing market is proj",
                "category": "company",
                "datetime": 1784815740,
                "headline": "In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region"
              },
              {
                "id": 140994723,
                "url": "https://finnhub.io/api/news?id=79fd17c84027588375b7e5a8a236ae382385fcb274c6606fa2b953d71a8ffca8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.",
                "category": "company",
                "datetime": 1784815260,
                "headline": "TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market"
              },
              {
                "id": 140993403,
                "url": "https://finnhub.io/api/news?id=e58cc899e08165b58f4e4fafe85b36bdfa2028d5ca8c7b98f2599623e735a726",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher stock led a medtech rebound Thursday, easing investors' fears of continued malaise for the medical research and tools realm.",
                "category": "company",
                "datetime": 1784814134,
                "headline": "The 'Standout Performance' That Could Save Thermo Fisher, Danaher And Others"
              },
              {
                "id": 140994724,
                "url": "https://finnhub.io/api/news?id=617cc09c000a0fc81628dbe24f6e706ea1af9395f146f411a6227d7d1aee1211",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
                "category": "company",
                "datetime": 1784813405,
                "headline": "Here's What Key Metrics Tell Us About Thermo Fisher (TMO) Q2 Earnings"
              },
              {
                "id": 140996085,
                "url": "https://finnhub.io/api/news?id=7ac6f8eab2e4b9f9c1240fd0f6bff9ce759557e835a200807298c057486a0f18",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/23/New-York--Usa---13-April-2025-The-Magnif.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.",
                "category": "company",
                "datetime": 1784812570,
                "headline": "Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today"
              },
              {
                "id": 140993247,
                "url": "https://finnhub.io/api/news?id=63d84d89c81d1f0a1d73a606412039f81336417a670af799d11ac30c83bf226e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "(Updates with economic data, recent oil price movement, world markets' overview and corporate stock",
                "category": "company",
                "datetime": 1784811109,
                "headline": "Update: US Equity Futures Drop Pre-Bell as Mid-East Conflict Expands to Potentially Include Red Sea"
              },
              {
                "id": 140993405,
                "url": "https://finnhub.io/api/news?id=fcb3c0126e7ea565b6fa6fea2431466ab240465c021b3f92024ec2e5723b5fde",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) reported better-than-expected second-quarter earnings on Thursday, driven by improving customer activity across its end markets and continued organic growth. The stronger results lifted investor sentiment, sending the life sciences company’s shares more than 3% higher in premarket trading.",
                "category": "company",
                "datetime": 1784810951,
                "headline": "Thermo Fisher beats second-quarter expectations as customer demand strengthens (NYSE:TMO)"
              },
              {
                "id": 140992858,
                "url": "https://finnhub.io/api/news?id=fc6e06457fb216266ed7ade2993afcedbedc6648f41f9685a003e7793ce61b00",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.",
                "category": "company",
                "datetime": 1784810101,
                "headline": "These S&P500 stocks that are showing activity before the opening bell on Thursday."
              },
              {
                "id": 140992426,
                "url": "https://finnhub.io/api/news?id=b7b5356534a23abb947720a998db3433c7c2ab8ce5896b2e8b9dccfd9cb97f87",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "US equity markets were tracking in the red before the opening bell Thursday and oil prices rose amid",
                "category": "company",
                "datetime": 1784806971,
                "headline": "Stocks Fall Pre-Bell Amid Rising Middle East Tensions; Traders Parse Alphabet, Tesla Results"
              },
              {
                "id": 140992281,
                "url": "https://finnhub.io/api/news?id=138961ab1629e06f057db765621f8d3cb045e31d9a422435208c64f34cf0addf",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific beat Q2 estimates with $11.99B revenue and $6.03 adjusted EPS, driving shares up 4.5% on strong margin expansion and 10% revenue growth.",
                "category": "company",
                "datetime": 1784805925,
                "headline": "Thermo Fisher Scientific (NYSE:TMO) Delivers Strong Earnings Beat as a Quality Stock"
              },
              {
                "id": 140993406,
                "url": "https://finnhub.io/api/news?id=375a73b22fbe217e83398cb76d9f216c243ca427e1a9c473b15e403144745624",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher (TMO) delivered earnings and revenue surprises of +5.60% and +2.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784805304,
                "headline": "Thermo Fisher Scientific (TMO) Surpasses Q2 Earnings and Revenue Estimates"
              },
              {
                "id": 140992543,
                "url": "https://finnhub.io/api/news?id=8b4b03d91fa7d83180cdce1af0bfd5d1221bdd925ae234f8ea4cc3bcf95ca7cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Investing.com--On Thursday, Thermo Fisher Scientific Inc. (NYSE: TMO) reported second quarter results that exceeded analyst expectations, as the company demonstrated strengthening customer activity across its end markets.",
                "category": "company",
                "datetime": 1784803112,
                "headline": "Thermo Fisher stock rises 3% on second quarter earnings beat"
              },
              {
                "id": 140993902,
                "url": "https://finnhub.io/api/news?id=7a5cfc6186cd9ffec5c304af7f0a23f3e13d78cfed2ff3b71b893a538836ec38",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/23/Orlando--Florida--Usa--February-8--2020-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11.4% on better-than-expected results. Other big gainers were NVE Corp (NVEC), Gibo Holdings Ltd (GIBO), Novocure Ltd (NVCR), Cleveland-Cliffs Inc (CLF), Merlin Inc (MRLN), Medpace Holdings Inc (MEDP), Oatly Group AB (OTLY), Imax Corp (IMAX), United Rentals Inc (URI), Oceaneering International Inc (OII), and Quest Diagnostics Inc (DGX).",
                "category": "company",
                "datetime": 1784802041,
                "headline": "Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday"
              },
              {
                "id": 140992544,
                "url": "https://finnhub.io/api/news?id=0b68415c7322ae12f9d2250ce1001bae2faccc15cdf98bfd54679318ff4fa79a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Life sciences company Thermo Fisher (NYSE:TMO) announced better-than-expected revenue in Q2 CY2026, with sales up 10.5% year on year to $11.99 billion. Its non-GAAP profit of $6.03 per share was 5.6% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784801840,
                "headline": "Thermo Fisher’s (NYSE:TMO) Q2 CY2026 Sales Top Estimates"
              },
              {
                "id": 140992545,
                "url": "https://finnhub.io/api/news?id=5f890ce3c1afd1a36d41e78b02b1bbb3ea8b4b74db8bf44c4ec73a8ea309c661",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., July 23, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 27, 2026.",
                "category": "company",
                "datetime": 1784800800,
                "headline": "Thermo Fisher Scientific Reports Second Quarter 2026 Results"
              },
              {
                "id": 140994309,
                "url": "https://finnhub.io/api/news?id=2a7e44dae359a77faaf7fa29ee4abd8bf8431f9392b6f5e5e1b64753951ae6b2",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) raises FY2026 Adj EPS guidance from $24.64-$25.12 to $24.93-$25.33 vs $24.86 analyst estimate. Raises FY2026 sales outlook from $47.300 billion-$48.100 billion to $47.400",
                "category": "company",
                "datetime": 1784799192,
                "headline": "Thermo Fisher Scientific Raises FY2026 Adj EPS Guidance from $24.64-$25.12 to $24.93-$25.33 vs $24.86 Est; Raises FY2026 Sales Guidance from $47.300B-$48.100B to $47.400B-$48.100B vs $47.767B Est"
              },
              {
                "id": 140994310,
                "url": "https://finnhub.io/api/news?id=bd4de4183c1ea327de07431f4bb7a72aca3f8301b98bf5ddde36a3c1b2409531",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "-Conference Call ",
                "category": "company",
                "datetime": 1784796677,
                "headline": "Thermo Fisher Scientific Exec Says Raising 2026 Revenue Forecast To Between $47.4B - $48.1B; Raising 2026 Adj EPS View To $24.93 - $25.33"
              },
              {
                "id": 140994311,
                "url": "https://finnhub.io/api/news?id=b5c7134a8d9dc9ef9211b63f00c1eb7a8461e18ccab4b85bf7f1702965dade02",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/23/The-Alarm-Clocks-Have-A-Sticker-With-The.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Earnings back in focus on Thursday, with a Benzinga-selected watchlist including Intel and Lockheed Martin. Options markets suggest a 4.64% swing for LMT and a 5.95% move for TMUS. Both have Buy ratings, but LMT is trading below analyst price forecast.",
                "category": "company",
                "datetime": 1784790998,
                "headline": "Intel Could Swing By $68.3 Billion After Earnings"
              },
              {
                "id": 140993809,
                "url": "https://finnhub.io/api/news?id=a47ad7f0bc8a271af3493561d9e532c43ff1705e233807236e6b2cf91a6dc883",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Companies Reporting Before The Bell\n• Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. \n• Dime Commercial (NYSE:DCOM) is expected to report",
                "category": "company",
                "datetime": 1784790711,
                "headline": "Earnings Scheduled For July 23, 2026"
              },
              {
                "id": 140994313,
                "url": "https://finnhub.io/api/news?id=f7f9f5cc578b231c12ec7e2b6e6aafb5f556745c31ab43d9acfd7c07bba32aea",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) reported quarterly earnings of $6.03 per share which beat the analyst consensus estimate of $5.71 by 5.6 percent. This is a 12.5 percent increase over earnings of $5.36 per share from",
                "category": "company",
                "datetime": 1784786431,
                "headline": "Thermo Fisher Scientific Q2 Adj. EPS $6.03 Beats $5.71 Estimate, Sales $11.994B Beat $11.701B Estimate"
              },
              {
                "id": 140990928,
                "url": "https://finnhub.io/api/news?id=7ce44440fd0e70fe296a452703a01c496dfa5980d5edf6b9a14c7e4cb8e1b8d4",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2194222153/image_2194222153.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "The global food safety testing market is projected to grow from $28.1 billion in 2026 to $52.9 billion by 2034, driving structural growth for the HTEC index.",
                "category": "company",
                "datetime": 1784772300,
                "headline": "Cyclosporiasis: Investing In Biosecurity"
              },
              {
                "id": 140983123,
                "url": "https://finnhub.io/api/news?id=24e492feb3f07919b7a09f23d71dff9b8240f4fe72bd06f30b4987100cf9a069",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. A copy of the letter can be downloaded here. Despite volatile oil prices and rising inflation, U.S. equities reached record highs in Q2 2026, driven by a technology-led rally, particularly in memory semiconductors. The Fund’s […]",
                "category": "company",
                "datetime": 1784730500,
                "headline": "What Makes Thermo Fisher Scientific (TMO) an Attractive Long-Term Bet?"
              },
              {
                "id": 140981877,
                "url": "https://finnhub.io/api/news?id=1e80e27ea0991bc9ca9dbae5a6894678650fc8cd88727163a63748920b424d8e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Life sciences company Thermo Fisher (NYSE:TMO) will be announcing earnings results this Thursday morning. Here’s what you need to know.",
                "category": "company",
                "datetime": 1784722947,
                "headline": "Earnings To Watch: Thermo Fisher (TMO) Reports Q2 Results Tomorrow"
              },
              {
                "id": 140980336,
                "url": "https://finnhub.io/api/news?id=a802e782a045e1db07bc8b05ecdf27fbd7bf41a71017f9a7cdb29f63e54a3c5b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Seeing Machines (AIM:SEE) has won a new driver monitoring contract with a European carmaker worth around $5 million in lifetime revenue, just as new EU safety rules make the technology mandatory on new vehicles. Production starts in 2028, with the system built into a rear-view mirror for easy deployment across multiple platforms. Frontier IP (LSE:FIPP) says portfolio company Cambridge Raman Imaging has secured a €400,000 European grant to scale up its AI-powered pharmaceutical quality control technology. The company has also appointed a China-based distributor with over 100 customers globally. ImmuPharma (AIM:IMM) has appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment Kapiglucagon. That completes the main manufacturing partnerships alongside Swiss group Bachem, which is handling the active ingredient. MP Evans (AIM:MPE) grew crude palm oil production 11% to 192,300 tonnes in the first half, supported by higher harvests across its Indonesian estates. Pricing also held firm at around $873 per tonne. Ariana Resources (AIM:AAU) says its Tavşan gold mine in Türkiye has completed its ramp-up and is now processing ore at the required rate of at least 4,000 tonnes a day. Gold recovery is tracking at around 70%. 88 Energy (AIM:88E) has moved its Augusta-1 Alaska well closer to a first-quarter 2027 spud after securing a rig and camp. Prospective resources at South Prudhoe have also been upgraded by 35%. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk. Read Proactive's Editorial Policy here: https://www.proactiveinvestors.co.uk/pages/editorialPolicy",
                "category": "company",
                "datetime": 1784708143,
                "headline": "Seeing Machines, Frontier IP, ImmuPharma, MP Evans, Ariana Resources, 88 Energy - Small Cap Snapshot"
              },
              {
                "id": 140963494,
                "url": "https://finnhub.io/api/news?id=7b31166bb1ac17998120320c49544beffe640cd6025723ffb890d3fb6b74eb37",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific’s board previously authorized a quarterly cash dividend of US$0.47 per share, paid on October 15, 2026, to shareholders of record on September 15, 2026. More recently, its Applied Biosystems RapidINTEL Plus Cartridge gained FBI approval for generating CODIS-searchable Rapid DNA crime scene profiles, expanding the company’s role in forensic workflows. We’ll now consider how FBI approval of Thermo Fisher’s RapidINTEL Plus Cartridge may influence the company’s...",
                "category": "company",
                "datetime": 1784571034,
                "headline": "How FBI Rapid DNA Approval Shapes Thermo Fisher Scientific’s (TMO) Long-Term Forensics Strategy"
              },
              {
                "id": 140962151,
                "url": "https://finnhub.io/api/news?id=bc1a98e96b4e11498f00fade91cdd2bd70ce566e182195bdf53a6a2cd283802c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific stock has delivered a 32.0% gain over the past year, and the latest Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside relative to the current US$532.48 share price, while broader valuation checks point to a more mixed picture. The 32.0% return over the last 12 months suggests sentiment has been positive, raising the bar for what counts as good value today. On the upside, recent acquisitions and collaborations in areas like mRNA therapies...",
                "category": "company",
                "datetime": 1784567276,
                "headline": "Thermo Fisher (TMO) Stock May Be Undervalued As Guidance Rises"
              },
              {
                "id": 140960709,
                "url": "https://finnhub.io/api/news?id=e3f971371cfde3111e605d3d634613baf912b30dd56a8fdf2a70e321240b1183",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
                "category": "company",
                "datetime": 1784553306,
                "headline": "Exploring Analyst Estimates for Thermo Fisher (TMO) Q2 Earnings, Beyond Revenue and EPS"
              },
              {
                "id": 140961307,
                "url": "https://finnhub.io/api/news?id=7add64cc4eb7f5bbb98d6693e33aeaab371046dfa8bd17b891b1b26c4612a2ac",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166895113/image_2166895113.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Quanterix (QTRX) turnaround: new management, Akoya synergies, biomarker growth and Alzheimer’s blood test. Cash-flow breakeven H2 2026.",
                "category": "company",
                "datetime": 1784549926,
                "headline": "Quanterix: Trading Below 1x Sales Despite A Changing Story"
              },
              {
                "id": 140961672,
                "url": "https://finnhub.io/api/news?id=7eeb8525665bb2d8614bcaf136195adbe17c37aa167811d0a13d0801471a69c0",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 20 years by 4.97% on an annualized basis producing an average annual return of 14.23%. Currently, Thermo Fisher Scientific has a market",
                "category": "company",
                "datetime": 1784546129,
                "headline": "Here’s How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years"
              },
              {
                "id": 140960936,
                "url": "https://finnhub.io/api/news?id=2c6b8b58a31f7aa66f8aa3b6773013169c86931d70da3969996fe4c331038e24",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/20/Quarterly-Results-Sales-Profits-Earnings.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Earnings season takes center stage next week with options markets pricing in big post-results moves. Benzinga selected top stocks to watch.",
                "category": "company",
                "datetime": 1784543345,
                "headline": "Intel Could Swing $61.4 Billion in Value After Earnings This Week"
              },
              {
                "id": 140939163,
                "url": "https://finnhub.io/api/news?id=2b7e563ff687d8cc979d3783bccd33f2bf9feb60d528dbd963b372e93e4735fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The healthcare giant's stock jump was about more than an earnings beat, offering proof of a growth story broader and more resilient than you thought.",
                "category": "company",
                "datetime": 1784328964,
                "headline": "Abbott Just Showed Its Growth Engine Has More Than One Cylinder"
              },
              {
                "id": 140931563,
                "url": "https://finnhub.io/api/news?id=9a8cdb541c3ef9be788480458508c8b7afe3ea54b0f0964b1a39fcf2f3561dab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "This healthcare giant is forecasting a significant acceleration, but you are being asked to look past a slowdown in its biggest growth engine and other execution hurdles.",
                "category": "company",
                "datetime": 1784290654,
                "headline": "Can Abbott Stock Deliver on Its Second-Half Growth Promise?"
              },
              {
                "id": 140930814,
                "url": "https://finnhub.io/api/news?id=d3dc1c2d69ab4e39d8aae41aa150cf946d1a48da7f86ea954cc9ed3844b19c84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Asia-Pacific will be the fastest-growing region. Key players include Roche, Thermo Fisher, Illumina, Agilent Technologies, and QIAGEN. Cancer Biomarkers Market Cancer Biomarkers Market Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The \"Cancer Biomarkers Market by Profiling Technology, Cancer, Product, Application, End User, And Region - Global Forecast to 2032\" has been added to ResearchAndMarkets.com's offering. Global market forecast indicates an 11.6% CAGR, with diagnostic laboratories holding th",
                "category": "company",
                "datetime": 1784285040,
                "headline": "Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate"
              },
              {
                "id": 140908375,
                "url": "https://finnhub.io/api/news?id=f4ed62597339749c83f097a34940712bf56323e909a7559924a9e9e18e26238e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.",
                "category": "company",
                "datetime": 1784119560,
                "headline": "Thermo Fisher Set to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 140898224,
                "url": "https://finnhub.io/api/news?id=4a3e47be628e3e7507616b74074fceaa3fe9ca6d9916945fc912e01a6834ee7a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Intuitive Surgical heads into Q2 earnings with strong procedure momentum, da Vinci 5 adoption and expectations for another earnings beat despite margin pressures.",
                "category": "company",
                "datetime": 1784037240,
                "headline": "Intuitive Surgical Pre-Q2 Analysis: Buy, Hold or Sell the Stock Now?"
              },
              {
                "id": 140898225,
                "url": "https://finnhub.io/api/news?id=b650bd0404d07d15723345af5bfd6859bfe7fe9df9d504ab0885e15a63cbfe95",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ABT heads into Q2 earnings results with growth expected across Diagnostics, Devices and EPD, while Nutrition remains a drag. Here's what could shape the results.",
                "category": "company",
                "datetime": 1784036040,
                "headline": "Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?"
              },
              {
                "id": 140891351,
                "url": "https://finnhub.io/api/news?id=e241c1ffe64c739ef93aa279e16d8b927df3ed6bdc10741dd02d51309b8e4eef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.",
                "category": "company",
                "datetime": 1783975817,
                "headline": "Alamar Hits A High Note On Alzheimer's Buzz"
              },
              {
                "id": 140885927,
                "url": "https://finnhub.io/api/news?id=476107059e36c9c3bd928f695f98309b2a569c0900ceea5cf136c1d6443a5d58",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "EMERYVILLE, Calif., July 13, 2026--OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, announces that it has appointed Amechi Nwachuku to the newly-created position of Executive Vice President and Chief Operating Officer, effective today. Mr. Nwachuku will be primarily responsible for managing the strategy, operations and commercial maximization of xPloration®, OmniAb’s proprietary, innovative high-throughp",
                "category": "company",
                "datetime": 1783944000,
                "headline": "OmniAb Names Amechi Nwachuku Chief Operating Officer"
              },
              {
                "id": 140855832,
                "url": "https://finnhub.io/api/news?id=72d6a3618c1c9b167c7e650ed0b69f647d05dc4bd4ef377f5cc12583360e10ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., July 09, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026.",
                "category": "company",
                "datetime": 1783630800,
                "headline": "Thermo Fisher Scientific Announces Quarterly Dividend"
              },
              {
                "id": 140851826,
                "url": "https://finnhub.io/api/news?id=72101a77e0588061d8f0271d4cf6c1e4816f95019f80268e544af4d51e48342b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2194222153/image_2194222153.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific Inc. stock is down 12% YTD amid NIH and China risks. Click for this TMO earnings preview and see if the stock is right for you.",
                "category": "company",
                "datetime": 1783596566,
                "headline": "Thermo Fisher Q2 Preview: Buy Before The Recovery"
              },
              {
                "id": 140851723,
                "url": "https://finnhub.io/api/news?id=adab0e54b2cd05edff59575e88d1eecd33a73d0980c3a0ffdfab4fcc4e7eb226",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442797246/image_1442797246.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know why the ILMN shares look promising.",
                "category": "company",
                "datetime": 1783595255,
                "headline": "Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat"
              },
              {
                "id": 140843465,
                "url": "https://finnhub.io/api/news?id=f84b04a78723a7ea755771a1895f2f4408dbda7c17f3ecbfaef31d98ca3f964e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "On the eve of the highly anticipated BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit successfully took place in San Diego. Hosted by bioSeedin and proudly supported by strategic partners Thermo Fisher Scientific and ACROBiosystems, the summit was uniquely designed as an international roadshow and licensing matchmaking platform dedicated to showcasing China's differentiated innovative assets.",
                "category": "company",
                "datetime": 1783526400,
                "headline": "On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations"
              },
              {
                "id": 140841784,
                "url": "https://finnhub.io/api/news?id=4396a662e7600562cf83917c492b3e31318e44cedf2049fa8b163483f1c8239f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient formulations provide the essential environment for growing and maintaining cells used in biopharmaceutical manufacturing, vaccine production, regenerative medicine, and advanced biomedical research.",
                "category": "company",
                "datetime": 1783526040,
                "headline": "Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG"
              },
              {
                "id": 140845008,
                "url": "https://finnhub.io/api/news?id=4a277941766a5de0378493dafe626ec2f71fa68672a90db59eec27da35febbda",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1783517708,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 140836511,
                "url": "https://finnhub.io/api/news?id=c27b66a84ad8e7e007c67be6965819a18c0a0ce5583d8f2aac9a20cf5cb770d0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "FBI approval of Thermo Fisher Scientific's RapidINTEL Plus Cartridge for forensic DNA profiling on the RapidHIT ID System. Rapid DNA workflows on RapidHIT ID can now generate profiles eligible for national CODIS database searches from qualifying crime scene samples. Approval enables law enforcement agencies to obtain actionable DNA intelligence within hours instead of longer traditional lab timelines. Regulatory milestone positions Thermo Fisher Scientific (NYSE:TMO) as a key player in next...",
                "category": "company",
                "datetime": 1783465917,
                "headline": "Thermo Fisher (TMO) Wins FBI Approval For Rapid DNA Tool In Crime Investigations"
              },
              {
                "id": 140833081,
                "url": "https://finnhub.io/api/news?id=b0014ec8d4702d066afdd40170bd94d682cbf383639c0f354276b70518ac12a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ICON trades below its five-year median, but weaker 2026 guidance, control issues and leverage keep the stock in wait-and-see territory.",
                "category": "company",
                "datetime": 1783441380,
                "headline": "Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset?"
              },
              {
                "id": 140830169,
                "url": "https://finnhub.io/api/news?id=ac82102e65e8fb28260365c3b6d43342d7cec3764ef9f45bd55cc84488d79f79",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "SAN FRANCISCO, July 07, 2026--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the nati",
                "category": "company",
                "datetime": 1783427400,
                "headline": "Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches"
              },
              {
                "id": 140834764,
                "url": "https://finnhub.io/api/news?id=082f618fcc759b3c73feecf0d2db5c0d2ae253e2a7c5e4b717e29729a67cac32",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA",
                "category": "company",
                "datetime": 1783413835,
                "headline": "Thermo Fisher Scientific's Applied Biosystems RapidINTEL Plus Cartridge Receives FBI's Approval For Use With Qualifying Forensic Crime Scene Samples"
              },
              {
                "id": 140823642,
                "url": "https://finnhub.io/api/news?id=3820f8eaebd3d9d4c79c9185413716efebd2aa61d4eaf563fdc2dd499d3c1d4b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ICON's stronger bookings and backlog hint at improving demand, but margin pressure, earnings declines and control remediation keep 2026 cautious.",
                "category": "company",
                "datetime": 1783362900,
                "headline": "ICON Stock Outlook 2026 as Margin Woes Meet a Stronger Backlog Base"
              },
              {
                "id": 140822551,
                "url": "https://finnhub.io/api/news?id=cee2ec535267e843a0b8f16ab25239634407c46036ba5069e90df7d6cd04facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Surplus Solutions LLC (\"Surplus Solutions\"), a portfolio company of NMS Capital (\"NMS\"), announced today the acquisition of DCM BioServices (\"DCM Bio\" or the \"Company\"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions. The acquisition expands Surplus Solutions' technical service capabilities and supports the Company's continued growth in the biotechnology, pharmaceutical, and life sciences sectors. Terms of the trans",
                "category": "company",
                "datetime": 1783358040,
                "headline": "Surplus Solutions, an NMS Capital Portfolio Company, Accelerates Technical Service Capabilities; Announces Partnership with DCM BioServices"
              },
              {
                "id": 140822991,
                "url": "https://finnhub.io/api/news?id=17f72a10b0544ab28833066b022947e98907839ac09695bdd7d2c169dddb3969",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962536/image_1386962536.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Medpace's outlook turns cautious as bookings, backlog, and cancellations worsen vs. CRO peers. Click for more on MEDP stock.",
                "category": "company",
                "datetime": 1783348133,
                "headline": "Medpace: The Recovery Narrative Looks Premature"
              },
              {
                "id": 140834765,
                "url": "https://finnhub.io/api/news?id=ea9c74b1352da018cf41af983e8efaa5c426d205008d80f01a879d8e080ee20b",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and lowers the price target from $575 to $570.",
                "category": "company",
                "datetime": 1783343001,
                "headline": "Evercore ISI Group Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $570"
              },
              {
                "id": 140821122,
                "url": "https://finnhub.io/api/news?id=bc1a01e4a3153aeaa577fecd21bc76829a5c301b0d3227ab5365e40dcf8bb30d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.",
                "category": "company",
                "datetime": 1783332000,
                "headline": "Top 10 medtech deals in the first half of 2026"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 6,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.8,
            "source_article_count": 91,
            "discarded_article_count": 69
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.4,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2338990,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2811610,
              "avg_vol_20": 2237480,
              "avg_vol_30": 2338990,
              "range_pct_10": 0.16291829046455678,
              "range_pct_20": 0.16291829046455678,
              "range_pct_30": 0.22585926423720235,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.2020615735851798,
              "dist_to_20d_high": 0.024687323297539646,
              "down_shrink_days": 2,
              "breakout_level_20d": 588.56,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7213265792518319
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.2248138711920933,
              "turnoverUsdM": 743.2902454410271,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.TMO",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 537.0072,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.5,
            "stop_loss_percent": 6.4,
            "take_profit_price": 628.3301,
            "target_multiplier": 2.2,
            "technical_strength": 2,
            "take_profit_percent": 9.5
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.472953227605692,
          "stopLossPercent": 6.449627742384187,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.TMO",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 18.5114,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.22
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 96.75
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.05
    },
    "kdj": {
      "d": 80.88,
      "j": 84.82,
      "k": 82.19,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 53.76
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 18577137,
      "recentSlope": 767793.7,
      "previousSlope": 129820
    },
    "rsi": 68.08,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 588.56,
      "position": "SAR喺價上",
      "distancePct": 2.53,
      "previousTrend": "上升"
    },
    "ma50": 507.2566,
    "macd": {
      "macd": 20.328298315515212,
      "trend": "強烈看漲",
      "signal": 18.532875692165,
      "histogram": 1.7954226233502126
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 549.0517,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 28
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.59,
      "score": 2,
      "avgVolume": 2209343,
      "currentVolume": 1294863
    },
    "derived": {
      "ma20": 545.314,
      "ma50": 507.2566,
      "prevClose": 574.3,
      "avgVolume10": 2782006,
      "avgVolume20": 2209343,
      "changePercent": -0.05,
      "avgVolumeForScore": 2209343
    },
    "ma_cross": {
      "ma20": 545.314,
      "ma50": 507.2566,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 542.4925,
      "prevMa50": 504.8118,
      "spreadPct": 7.5,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 498.958,
      "upper": 591.67,
      "position": "上半部"
    },
    "rsi_short": 60.05,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.59
    }
  }
}

{
  "close": 574.03,
  "volume": 1294863,
  "changePercent": -0.05
}